Funding Resources

To assist HIV/AIDS scientists at UCSF and our partner institutes in developing extramural funding, our Administrative Core reviews HIV-relevant program and grant announcements and posts this funding information on our website. In addition, we distribute an electronic update of announced and pending funding opportunities to all CFAR members, with particular emphasis on program grant announcements focused on translational projects. This update lists federal grant opportunities, state, and private foundation programs for HIV/AIDS research. Subscribe online to receive CFAR's updates.

Title Dates
Youth Mental & Sexual Health Research Call for Applications 2022 LOI:
APP:
Community-Centered Research Collaboratives to Address Local HIV-Related Syndemics Across California LOI:
APP:
Planning Grant for Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D71 Clinical Trial Not Allowed)
Number: PAR-22-152
LOI:
APP:
Enhancing HIV Reservoir Susceptibility to Elimination (R01 Clinical Trial Not Allowed)
Number: RFA-AI-22-025
LOI:
APP:
Limited Interaction Targeted Epidemiology: Viral Suppression (LITE-VS) (UG3/UH3 Clinical Trial Optional)
Number: RFA-AI-22-024
LOI:
APP:
Integrating Mental Health Care into Health Care Systems in Low- and Middle-Income Countries (R01 Clinical Trial Optional)
Number: RFA-MH-22-130
LOI:
APP:
Pathogenic Mechanisms influencing Blood Brain Barrier function in HIV and Substance Use Disorders (R01 Clinical Trial Optional)
Number: RFA-DA-23-012
LOI:
APP:
Implementing Comprehensive HIV services in Syringe Service Program (SSP) Settings (R34 - Clinical Trial Required)
Number: RFA-DA-23-007
LOI:
APP:
Implementing Comprehensive HIV services in Syringe Service Program (SSP) Settings (R01 - Clinical Trial Required)
Number: RFA-DA-23-006
LOI:
APP:
Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)
Number: PAR-22-151
LOI:
APP:
Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11 Clinical Trials Not Allowed)
Number: PAR-22-153
LOI:
APP:
Notice of Special Interest (NOSI): Towards Developing a Cure for HBV in HIV/HBV Co-Infection
Number: NOT-AI-22-043
APP:
Notice of Special Interest (NOSI): Sustained Release of Antivirals for Treatment or Prevention of HIV or Treatment of Latent TB/HBV (SRATP)
Number: NOT-AI-22-042
APP:
Understanding the role of Gut Immune dysfunction and Gut Microbiome in pathogenesis of Central Nervous System co-morbidities in people living with HIV (R21 Clinical Trial Not Allowed)
Number: RFA-MH-22-230
LOI:
APP:
NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)
Number: NOT-MH-22-020
LOI:
Standard AIDS dates apply
EXP:
Getting To Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Optional)
Number: PAR-20-036
Standard AIDS dates apply
EXP:
NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)
Number: PAR-20-150
Standard AIDS dates apply
EXP:
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
Number: PA-21-071
Standard AIDS dates apply
EXP: